Stryker remains on track to deliver Mako shoulder and spine applications in 2024, CEO Kevin Lobo said in an Aug. 3 earnings call.
Mr. Lobo said in the call he wasn't concerned about competition in the spine and orthopedic robotic space and pointed to upcoming developments within the company.
"We are really excited about our overall enabling technology starting with Q Guidance," Mr. Lobo said, as transcribed by Seeking Alpha. "We have an additional product that we’ll be launching and Mako Spine. So, by the end of next year we’ll have a really compelling suite of enabling technology tools for Spine, which we’re really excited about."
For the upcoming shoulder robot, Mr. Lobo expressed confidence in Stryker's current digital platform, Blueprint.
"If someone else is first in shoulder it doesn’t concern me in the least," he said. "We have Blueprint already. We already have a very powerful enabling tech platform for shoulder, whether it’s patient matched ID, whether it’s using HoloLens to do the procedure with virtual reality, whether it’s the Blueprint technology, which is amazing. And we’re going to use that amazing Blueprint technology to feed Mako, and that will just be icing on the cake on an upper extremity business that is cooking on gas right now with amazing growth quarter after quarter after quarter."